1st Quarter - Report

TIBER CREEK GROUP for JAZZ PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products; Ag/ FDA amendment - technical correction to the 2025 Ag/ FDA appropriations bill related to hemp; Issues related to intoxifying hemp products.

LobbyistCovered position, as disclosed
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.